Susan Marlin

By August 4, 2026

Susan Marlin

President & CEO, Clinical Trials Ontario

Susan Marlin is an experienced leader in Canada’s research ethics and clinical trials community. As the President and CEO of Clinical Trials Ontario (CTO), Susan collaborates to strengthen Ontario's clinical trials environment, bring more trials to the people who need them, and fuel a thriving life sciences sector.

Susan was foundational in establishing Stream, CTO’s streamlined research ethics review platform to enable a single review for multi-site clinical trials and health research studies, now widely adopted in Ontario. Under Susan's leadership, CTO also launched QuickSTART, Ontario's accelerated clinical trials pathway to enable study start-up within 45 days. A champion of patient and public engagement in clinical trials, Susan continues to establish CTO as a central hub for Ontario’s trials community, connecting diverse interest holders, advancing innovation, and showcasing the province’s strengths through initiatives such as CTO’s annual conference.

Susan played a leading role in the Canada-wide CHEER project, supported by the Canadian Institutes of Health Research (CIHR) to streamline ethics reviews for child health research. She continues to advance Canada-wide collaboration as the nominated principal applicant for CanReview, working with leaders across the country to establish Canada’s first pan-Canadian single research ethics review system, which leverages the Stream platform. She is also played a leading role in the development of the Canadian Research Ethics Board Training Program at Queen's University, Canada’s first REB online education program.

Prior to CTO, Susan served as the Associate Vice-Principal at Queen’s University, working with the Canadian Cancer Trials Group to coordinate clinical trials and lead the development and implementation of the Ethics and Regulatory Office. Susan has served as President of the Canadian Association of Research Ethics Boards, and as a member of the CIHR Research Integrity Committee, the Ontario Cancer Research Ethics Board, and the Tri-Agency Panel on the Responsible Conduct of Research. Susan sits on the Board of

Directors and Executive Committee of Life Sciences Ontario and on the Board of Directors for the Stem Cell Network. She serves on the Operations Committee and is co-chair of the Ethics Committee for the ACT Consortium, and she is on the Management Team for the Ontario Strategy for Patient-Oriented Research Support Unit. Susan is a Queen's Institute for Educational Scholarship and Research (QIESR) Invited Scholar and an Adjunct Lecturer at Queen’s University in Kingston, Ontario.